首页> 外文期刊>Journal of autoimmune diseases >The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
【24h】

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders

机译:修订的国际慢性肝病自身免疫性肝炎评分,包括自身免疫性肝炎/重叠综合征和自身免疫性肝炎并发其他肝病

获取原文
           

摘要

Background We conducted a study in order to determine the usefulness and diagnostic value of International Autoimmune Hepatitis Group (IAHG) score in non-autoimmune hepatitis (AIH) hepatic disorders as well as in AIH/overlap syndromes and in cases with coexistence of AIH and other liver diseases. Methods We applied the IAHG score in 423 patients with liver diseases excluding patients with AIH, AIH/overlap syndromes and AIH with concurrent other liver disease namely, patients with chronic hepatitis B (n = 109), chronic hepatitis C (n = 95), chronic hepatitis D (n = 4), alchoholic liver disease (n = 28), non-alcoholic fatty liver disease (n = 55), autoimmune cholestatic liver diseases (n = 77), liver disorders of undefined origin (n = 32) and with miscellaneous hepatic disorders (n = 23). 24 patients with AIH associated with any kind of liver disorder including 10 patients with AIH/overlap syndromes and 14 AIH with concurrent other liver disease were also investigated. 43 patients with AIH consisted the control group. Results The specificity of the score was 98.1% while the sensitivity in unmasking AIH in patients with either AIH/overlap syndromes or AIH with concurrent other liver diseases was only 50% and 78.6%. In the binary logistic regression model, the presence of other autoimmune diseases (p < 0.001), the total histological score (p < 0.001) and positivity for autoantibodies (p < 0.05) were identified as independent predictors for the presnce of AIH/ovea syndromes o AI with concurren other liver diseass. Conclusion The IAHG scoring system has very good specificity for excluding AIH in patients with chronic liver diseases but not that sensitivity in order to unmask AIH/overlap syndromes or AIH with concurrent other liver diseases. The presence of other autoimmune diseases or autoantibody markers in the absence of hepatitis viral markers should alarm physicians for the possible presence of AIH either as "pure" AIH or in association with other liver disorders (AIH/overlap syndromes or AIH with concurrent other liver diseases). Under these conditions, liver histology seems essential and it must always be included in the work up of hepatic patients.
机译:背景我们进行了一项研究,以确定国际自身免疫性肝炎组(IAHG)评分在非自身免疫性肝炎(AIH)肝病以及AIH /重叠综合征以及AIH与其他疾病共存的病例中的有用性和诊断价值肝脏疾病。方法我们将IAHG评分应用于423例肝病患者,但不包括AIH,AIH /重叠综合征和AIH并发其他肝病的患者,即慢性乙型肝炎(n = 109),慢性丙型肝炎(n = 95),慢性D型肝炎(n = 4),酒精性肝病(n = 28),非酒精性脂肪肝病(n = 55),自身免疫性胆汁淤积性肝病(n = 77),来源不明的肝病(n = 32)并伴有其他肝病(n = 23)。还调查了24例与任何类型肝病相关的AIH患者,包括10例AIH /重叠综合征患者和14例同时发生其他肝病的AIH。对照组为43例AIH患者。结果得分的特异性为98.1%,而AIH /重叠综合征或合并其他肝病的AIH患者暴露AIH的敏感性分别仅为50%和78.6%。在二元logistic回归模型中,将其他自身免疫性疾病(p <0.001),总组织学评分(p <0.001)和自身抗体阳性(p <0.05)的存在确定为AIH /卵泡综合征存在的独立预测因子o AI与其他肝脏疾病并存。结论IAHG评分系统对排除慢性肝病患者的AIH具有很好的特异性,但对于揭示AIH /重叠综合征或并发其他肝病的AIH则没有那么高的敏感性。在没有肝炎病毒标志物的情况下,存在其他自身免疫性疾病或自身抗体标志物,应警告医生可能存在的AIH是“纯” AIH或与其他肝病(AIH /重叠综合征或合并其他肝病的AIH) )。在这种情况下,肝组织学似乎至关重要,必须始终将其纳入肝病患者的检查中。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号